New Soviet Weekly Pushes For Perestroika In Science

If the editors of Poisk, a lively new science newspaper published in Moscow, need historical justification for their project, they can point to Lenin, who on his deathbed in 1922 called for a newspaper that would provide a forum for scientists. Or the editors can produce the letter Soviet physicist Pyetr Kapitsa wrote to Nikita Khrushchev in 1958 on behalf of his colleagues at the Soviet Academy of Sciences. Kapitsa, who would later win the Nobel Prize in physics, humbly wrote: "I would like t

Written byKen Kalfus
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

If the editors of Poisk, a lively new science newspaper published in Moscow, need historical justification for their project, they can point to Lenin, who on his deathbed in 1922 called for a newspaper that would provide a forum for scientists.

Or the editors can produce the letter Soviet physicist Pyetr Kapitsa wrote to Nikita Khrushchev in 1958 on behalf of his colleagues at the Soviet Academy of Sciences. Kapitsa, who would later win the Nobel Prize in physics, humbly wrote: "I would like to bring to Your attention the fact that for the successful resolution of scientific work in this country, creation of such a periodic newspaper has become increasingly necessary."

Poisk, however, is clearly a product of the Age of Gorbachev. The 8-page, 5-kopeck weekly newspaper (about a nickel in U.S. currency), published since May, offers its 250,000 readers an engaging mix of investigative journalism, politics, and exclusive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies